The American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine have jointly released a landmark publication that redefines heart health for girls and women. Published on October 26, 2026, in the American Heart Association's flagship journal Circulation, the three manuscripts represent the first coordinated, multi-society framework to prevent, detect, and manage cardiovascular disease across the female lifespan.
The new approach, termed the "Female Life Stage" framework, divides a woman's life into four distinct stages based on hormonal changes: perimenarche (around the first menstrual period, ages 8-15), ovarian cycling (ages 15-44), perimenopause (ages 45-51), and postmenopause (51 and older). Pregnancy is recognized as a biological "stress test" that can occur at any stage and may unmask previously unrecognized cardiovascular risks. This framework aims to connect care across clinical specialties that often operate in silos.
Cardiovascular disease is the leading cause of death in women, claiming more than 400,000 lives in the U.S. annually—more than breast cancer, lung cancer, and chronic lung disease combined. Yet only about 41% of women recognize it as their greatest health threat. A 2026 American Heart Association scientific statement projected that if trends continue, the proportion of U.S. women ages 20 and older with high blood pressure will rise from approximately 49% in 2020 to 59% by 2050. Additionally, maternal mortality has increased, with cardiovascular disease now the leading cause of pregnancy-related deaths, accounting for more than one-third of such deaths in the U.S.
The publications highlight female-specific risk markers, including menstrual cycle patterns as a vital sign. Heavy or irregular bleeding can signal conditions like polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS). Perimenopause is described as a cardiovascular inflection point, with changes in cholesterol and metabolic health serving as early warning signs. The 2026 American Heart Association/American College of Cardiology cholesterol guideline now incorporates pregnancy-related factors into risk assessment for women.
To translate evidence into practice, the societies call for a national network of Comprehensive Centers of Excellence for Women's Cardiovascular Care, built on four pillars: interdisciplinary clinical care, professional education and training, research, and community engagement. They also advocate for broader use of the American Heart Association's PREVENT equations, which enable 10- and 30-year sex-specific risk estimation.
The framework is detailed in three papers: a presidential advisory, A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease; a scientific statement, Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease; and a science advisory, Comprehensive Centers of Excellence for Women's Cardiovascular Care. These documents provide clinicians with shared guidance to recognize risk earlier, personalize prevention, and act before events occur.
For the public, the American Heart Association offers resources such as an infographic guide, A Woman’s Heart Through Every Stage of Life - A guide to protecting your heart from your first period through menopause and beyond, and a checklist, My Heart & Health Checklist - Questions to think about before your next visit. Additional information is available on heart.org and stroke.org. The original release can be viewed on www.newmediawire.com.
